Jessica R de Bruyn1, Sybren L Meijer2, Manon E Wildenberg1, Willem A Bemelman3, Gijs R van den Brink1, Geert R D'Haens4. 1. Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands Tytgat Institute for Liver and Intestinal Research, Academic Medical Center, Amsterdam, The Netherlands. 2. Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands. 3. Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands. 4. Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands Tytgat Institute for Liver and Intestinal Research, Academic Medical Center, Amsterdam, The Netherlands g.dhaens@amc.uva.nl.
Abstract
BACKGROUND: Intestinal fibrosis is a process driven by chronic inflammation leading to increased presence of myofibroblasts and collagen deposition. Although strictures are rarely seen in ulcerative colitis [UC], longstanding disease is believed to cause fibrosis resulting in altered bowel function. METHODS: The presence of fibrosis was studied in colectomy specimens from patients with recent-onset UC refractory to medical treatment [n = 13] and longstanding UC [n = 16], and colon cancer patients without UC [n = 7] as controls. Severity of inflammation was scored according to the Geboes score on haematoxylin and eosin stainings. Immunohistochemistry was performed to detect α-smooth muscle actin, fibronectin and collagen I and III. RESULTS: Colectomy specimens from patients with acute UC showed significantly more inflammation than those with longstanding disease [19 vs 9 points, p = 0.01]. Both acute and longstanding UC showed a thicker muscularis mucosa than controls [0.10 vs 0.10 vs 0.05 mm, respectively, p = 0.019]. An increase in collagen I and III deposition in the mucosa was observed in UC compared with controls (40% [30-75] vs 25% [10-25], p = 0.033), but this did not differ significantly among acute and longstanding UC patients. CONCLUSIONS: Collagen deposition is enhanced in UC compared with controls. However, UC collagen deposition does not increase significantly over time and does not seem to aggravate the entire fibrotic process.
BACKGROUND: Intestinal fibrosis is a process driven by chronic inflammation leading to increased presence of myofibroblasts and collagen deposition. Although strictures are rarely seen in ulcerative colitis [UC], longstanding disease is believed to cause fibrosis resulting in altered bowel function. METHODS: The presence of fibrosis was studied in colectomy specimens from patients with recent-onset UC refractory to medical treatment [n = 13] and longstanding UC [n = 16], and colon cancerpatients without UC [n = 7] as controls. Severity of inflammation was scored according to the Geboes score on haematoxylin and eosin stainings. Immunohistochemistry was performed to detect α-smooth muscle actin, fibronectin and collagen I and III. RESULTS: Colectomy specimens from patients with acute UC showed significantly more inflammation than those with longstanding disease [19 vs 9 points, p = 0.01]. Both acute and longstanding UC showed a thicker muscularis mucosa than controls [0.10 vs 0.10 vs 0.05 mm, respectively, p = 0.019]. An increase in collagen I and III deposition in the mucosa was observed in UC compared with controls (40% [30-75] vs 25% [10-25], p = 0.033), but this did not differ significantly among acute and longstanding UC patients. CONCLUSIONS: Collagen deposition is enhanced in UC compared with controls. However, UC collagen deposition does not increase significantly over time and does not seem to aggravate the entire fibrotic process.
Authors: Paolo Giuffrida; Massimo Pinzani; Gino R Corazza; Antonio Di Sabatino Journal: United European Gastroenterol J Date: 2016-03-21 Impact factor: 4.623
Authors: Christopher Ma; William J Sandborn; Geert R D'Haens; Guangyong Zou; Larry W Stitt; Siddharth Singh; Ashwin N Ananthakrishnan; Parambir S Dulai; Reena Khanna; Vipul Jairath; Brian G Feagan Journal: Clin Gastroenterol Hepatol Date: 2019-09-20 Impact factor: 11.382
Authors: I O Gordon; N Agrawal; E Willis; J R Goldblum; R Lopez; D Allende; X Liu; D Y Patil; L Yerian; F El-Khider; C Fiocchi; F Rieder Journal: Aliment Pharmacol Ther Date: 2018-02-06 Impact factor: 8.171